Cardiomyopathy registry for tracking heart disease
Part of Heart & circulation clinical trials.
This study builds a patient registry to collect information over time about several types of cardiomyopathy (heart muscle diseases). It may help researchers understand how these conditions progress and what care works best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed cardiomyopathy type (HCM, DCM, ACM, RCM, or related conditions).
- Examples of eligible diagnoses may include cardiac amyloidosis, Fabry disease, Pompe disease, Danon disease, or PRKAG2 heart syndrome.
- You must be willing to sign informed consent.
- You must be willing to complete follow-up visits or check-ins after enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This trial aims to better understand and treat cardiomyopathy by studying patients' hearts with advanced tests. It seeks to find new ways to prevent or manage the condition early.
This study collects health records, heart ultrasound (echo), MRI images, and optional DNA testing for people with hypertrophic cardiomyopathy (HCM). It aims to build a large database to better understand HCM and support future research and care.
This study builds a registry and collection of samples to better understand families affected by sudden heart death and related heart rhythm problems that are not clearly caused by a heart attack. It may help researchers identify patterns and improve future care, and it offers a way for patients and families to contribute to research.
This trial is a registry, meaning it collects health information to help doctors study heart muscle diseases and plan future cardiovascular studies. You may be able to join if you have a non-ischemic cardiomyopathy such as dilated cardiomyopathy, certain forms of thick heart muscle, non-compaction, or arrhythmogenic right-sided disease.
This study enrolls people with certain types of heart muscle diseases to learn how blocked heart arteries and tiny blood vessels affect symptoms and outcomes. It may help researchers better understand these conditions and improve future care.
Hear when a new Cardiomyopathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.